Disease details

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01259388 (ClinicalTrials.gov)	May 2011	10/12/2010	A Pilot Study of Lithium in Progressive Multiple Sclerosis	A Pilot Trial of Lithium in Progressive Multiple Sclerosis	Multiple Sclerosis	Drug: Lithium Carbonate	VA Office of Research and Development	NULL	Completed	30 Years	65 Years	All	23	Phase 1/Phase 2	United States
2	NCT00785473 (ClinicalTrials.gov)	January 2008	4/11/2008	Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis	Can Vitamin D Supplementation Prevent Bone Loss in Persons With MS? A Randomised, Placebo-controlled, Single-centre Study	Multiple Sclerosis, Osteoporosis	Dietary Supplement: cholecalciferol;Dietary Supplement: calcium carbonate	University Hospital of North Norway	NULL	Completed	18 Years	50 Years	Both	80	Phase 4	Norway